Why Nutanix Shares Are Trading Higher By 9%; Here Are 20 Stocks Moving Premarket
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Nov 27 2024
0mins
Source: Benzinga
Nutanix Financial Results: Nutanix, Inc. shares rose 8.8% in pre-market trading after reporting first-quarter earnings of 42 cents per share and sales of $590.96 million, both exceeding analyst expectations.
Stock Movements: Various stocks saw significant movements in pre-market trading, with notable gainers including HWH International Inc. (+82.1%) and Cyclerion Therapeutics, Inc. (+72.8%), while Primega Group Holdings Limited experienced a sharp decline of 89.2%.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy CMCT?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on CMCT
About CMCT
Creative Media & Community Trust Corporation is a real estate investment trust. The Company is a vertically integrated community-focused real estate and infrastructure owner, operator, lender and developer. It primarily acquires, develops, owns, and operates both premier multifamily properties situated in communities throughout the United States and Class A and creative office real assets in markets. Its segments consist of three types of commercial real estate properties, namely office, hotel and multifamily, as well as a segment for the Company’s lending business. The products for the Company’s office segment primarily include rental of office space and other tenant services, including tenant reimbursements, parking, and storage space rental. The products for the Company’s hotel segment include operations of hotel properties. The loan segment includes the sale of the government-guaranteed portion of loans receivable and income from the yield on its loans receivable.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Abbott Laboratories (ABT) Reports Q4 Sales Below Expectations, Stock Drops 7%
- Sales Performance Miss: Abbott Laboratories reported Q4 2025 sales of $11.46 billion, slightly below the consensus estimate of $11.80 billion, with a 4.4% increase in sales but only 3% organic growth, indicating competitive pressure in the market.
- Earnings Outlook Disappointment: Although adjusted earnings per share of $1.50 met Wall Street expectations, the overall performance failed to boost investor confidence, resulting in a stock drop of over 7% on Thursday, reflecting concerns about future growth.
- Market Reaction Intense: Following Abbott's earnings report, the significant stock decline illustrates investor pessimism regarding the company's future performance, which may impact its market position in the MedTech sector.
- Industry Impact Significant: Abbott's disappointing results could trigger a ripple effect across the MedTech industry, prompting investors to reassess the financial health of other related companies, potentially leading to overall valuation fluctuations in the sector.
Continue Reading
CMCT Completes $44.9M Sale of Lending Division, Shares Surge 55%
- Stock Surge: CMCT's completion of the sale of its lending division to PG FR Holding, LLC for approximately $44.9 million resulted in a 54.96% increase in share price to $4.5403, indicating strong market confidence in the company's strategic shift.
- Cash Flow Improvement: The transaction yielded about $31.2 million in net cash proceeds after debt payments and transaction costs, significantly enhancing CMCT's liquidity to support its multifamily property investment strategy.
- Strategic Focus: By divesting this division, CMCT has strengthened its balance sheet and improved liquidity, shifting operational emphasis toward multifamily properties to enhance financial stability and long-term growth potential.
- Strong Market Reaction: On the announcement day, CMCT's stock opened lower but experienced heavy buying pressure, with trading volume significantly above average, reflecting investor enthusiasm for the company's renewed focus on core real estate operations.
Continue Reading